Skip to main content
Publications
Kirkeleit J, Riise T, Wielscher M, Accordini S, Carsin AE, Dratva J, Franklin KA, Garcia-Aymerich J, Jarvis D, Leynaert B, Lodge CJ, Real FG, Schlunssen V, Corsico AG, Heinrich J, Holm M, Janson C, Benediktsdottir B, Jogi R, Dharmage SC, Jarvelin MR, Svanes C. Early life exposures contributing to accelerated lung function decline in adulthood - a follow-up study of 11,000 adults from the general population. EClinicalMedicine. 2023 Dec 8;66:102339. doi: 10.1016/j.eclinm.2023.102339
Winfree KB, Ainsworth C, Njue A, Molife C, Lyall M, Jen M-H, Bittoni M, Heyes A, Carbone DP. Defining aggressive disease in patients with advanced NSCLC receiving second-line treatment: a systematic review. Poster presented at the IASLC 19th World Conference on Lung Cancer; September 26, 2018. Toronto, Canada. [abstract] J Thorac Oncol. 2018 Oct; 13(10 (Suppl)):5908. doi: 10.1016/j.jtho.2018.08.1671
Carrasquilla G, Porras A, Martinez S, DeAntonio R, Devadiga R, Talarico C, Caceres D, Juliao P. Pneumococcal disease mortality in children<5 years of age after pneumococcal conjugate vaccine introduction in Colombia: a time-trend analysis, 2005-2016. Poster presented at the 18th International Congress on Infectious Diseases (ICID); March 1, 2018. Buenos Aires, Argentina. [abstract] International journal of infectious diseases and therapy. 2018 Aug; 73(Supplement). doi: 10.1016/j.ijid.2018.04.3922